While regulatory approval remains the endgame for any device or drug maker, positive trial results can move the share price needle more.
Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.
Argent BioPharma has signed a binding term sheet to acquire the key assets and intellectual property of AusCann Group in a deal worth around US$15 million.
Mark Creasy is one of the most influential resources investors on the ASX, and this year a couple of his small caps have been running hard.
ASX gold explorer Ballard Mining is investing heavily in drilling to expand and make new discoveries at its 1.1Moz Mt Ida gold project.
